Lewis Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,907
Closed -$245K 221
2026
Q1
$245K Hold
3,907
0.1% 175
2025
Q4
$373K Hold
3,907
0.15% 133
2025
Q3
$381K Hold
3,907
0.16% 129
2025
Q2
$420K Hold
3,907
0.2% 122
2025
Q1
$394K Sell
3,907
-50
-1% -$5.04K 0.33% 78
2024
Q4
$353K Hold
3,957
0.27% 92
2024
Q3
$332K Hold
3,957
0.24% 97
2024
Q2
$305K Hold
3,957
0.23% 93
2024
Q1
$271K Buy
3,957
+50
+1% +$3.21K 0.22% 99
2023
Q4
$226K Buy
+3,907
New +$209K 0.21% 97

Other funds holding BSX

Lewis Asset Management's BSX Position: Q2 2026 in Review

Lewis Asset Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,907 shares — an estimated $245K sold.

Lewis Asset Management first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $420K in Q2 2025. 529 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Lewis Asset Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Lewis Asset Management sold 3,907 Boston Scientific shares in Q2 2026, an estimated $245K.
  • Lewis Asset Management first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
  • Lewis Asset Management's Boston Scientific position peaked at $420K in Q2 2025.
  • 529 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lewis Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.